Ps0009 913 — New York, New York

Ps0009 913 is a clinical research site located in New York, New York, United States 10029-65.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Ps0009 913 has participated in 1 clinical trials.

Therapeutic areas: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis.

Sponsors: UCB Biopharma SRL.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Ps0009 913?

Ps0009 913 has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Ps0009 913 conducted?

Ps0009 913 has 1 clinical trials on record. Their work covers Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis, Psoriatic Arthritis.

Is Ps0009 913 accredited by Crixeo Health?

Ps0009 913 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Ps0009 913?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.